The aim of this study was to evaluate the expression of genes for selected enzymes with antioxidant properties (paraoxonases PON1, PON2 and PON3 and myeloperoxidase MPO) at the mRNA and protein levels in patients with depressive disorders and to determine their impact in the etiopathogenesis of depression. This evidence concerns the gene PON1 and depressive symptom measurement.